Completed

A Study of LY3361237 in Participants With Systemic Lupus Erythematosus

I9S-MC-BTAB - ClinicalTrials.gov - NCT03933943

The main purpose of this study is to learn more about the safety of LY3361237 and any side effects that might be associated with it when given to participants with systemic lupus erythematosis (SLE). LY3361237 will be administered by injections just under the skin.
How long will I be in the trial?
The study will last up to 26 weeks and may include up to 17 visits to the study center.
Email
Completed

A Study of LY3361237 in Participants With Systemic Lupus Erythematosus

I9S-MC-BTAB - ClinicalTrials.gov - NCT03933943

The main purpose of this study is to learn more about the safety of LY3361237 and any side effects that might be associated with it when given to participants with systemic lupus erythematosis (SLE). LY3361237 will be administered by injections just under the skin.
How long will I be in the trial?
The study will last up to 26 weeks and may include up to 17 visits to the study center.
Email

Key Requirements

Age :

18-70

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-70

Sex

All

Participants must

Participants must have been diagnosed with SLE at least 6 months before enrollment

Participants taking an oral steroid called prednisone (or equivalent) must be taking no more than 20 milligrams for at least 2 months and must be on a stable dose.

Participants taking other common medications for SLE must be on the medication for at least 3 months with a stable dose for at least 2 months.

Participants must NOT

Participants must not have or have had any other diseases that cause inflammation of the joints or skin.

Participants must not have an active infection.

Participants must not have serious liver or kidney dysfunction.

Participants must not have taken medications to destroy cancer cells within the last 3 months

Participants must not have had a blood transfusion within the last year.

Trial Summary

Conditions the trial is for

Lupus (SLE)

What the trial is testing?

LY3361237, Placebo

Could I receive a Placebo?

yes

Enrollment Goal

24

Trial Dates

May 2019 - February 2021

Trial Phase

1

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-70

Sex

All

Participants must

Participants must have been diagnosed with SLE at least 6 months before enrollment

Participants taking an oral steroid called prednisone (or equivalent) must be taking no more than 20 milligrams for at least 2 months and must be on a stable dose.

Participants taking other common medications for SLE must be on the medication for at least 3 months with a stable dose for at least 2 months.

Participants must NOT

Participants must not have or have had any other diseases that cause inflammation of the joints or skin.

Participants must not have an active infection.

Participants must not have serious liver or kidney dysfunction.

Participants must not have taken medications to destroy cancer cells within the last 3 months

Participants must not have had a blood transfusion within the last year.

Trial Summary

Conditions the trial is for

Lupus (SLE)

What the trial is testing?

LY3361237, Placebo

Could I receive a Placebo?

yes

Enrollment Goal

24

Trial Dates

May 2019 - February 2021

Trial Phase

1

Not the right fit? Sign up to receive updates on new Lupus (SLE) trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

By clicking the checkbox and using the map, you agree to allow Google Maps to collect your personal information in accordance with their Privacy Policy

Lupus (SLE) Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?